An Open-Label Study Of The Use Of Topical Lidocaine (2.5%)/Prilocaine (2.5%) Cream As Pre-Treatment For NGX-4010 In Subjects With Postherpetic Neuralgia (PHN).

Trial Profile

An Open-Label Study Of The Use Of Topical Lidocaine (2.5%)/Prilocaine (2.5%) Cream As Pre-Treatment For NGX-4010 In Subjects With Postherpetic Neuralgia (PHN).

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Capsaicin; Lidocaine/prilocaine
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Adverse reactions
  • Sponsors NeurogesX
  • Most Recent Events

    • 10 Sep 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2009 Interim results announced in a NeurogesX media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top